Severe Asthma

SAN DIEGO — Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and 2023, according to a poster presented here.

Blood tests for cyclic adenosine monophosphate may be a simple and useful option for diagnosing asthma and determining its severity, according to a study published in The Journal of Clinical Investigation.

BOSTON — The TIDE-Asthma study used specific enrollment strategies to increase study population diversity, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — ICU patients with an eosinophilic asthma phenotype had longer ICU and hospital stays compared with patients without an eosinophilic asthma type, according to an abstract presented at the CHEST Annual Meeting.

Asthma increased the need for respiratory support in COVID-19 patients, whereas metabolic syndrome raised the risk for severe COVID-19, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

As fall draws near, so does the season for viruses and environmental allergens, which can trigger asthma. Experts say that with children returning to school and the season changing, allergists can expect to see an increase in patients.

While attending a conference in Canada, Sarah A. Bendien, MD, a respiratory physician at Haga Teaching Hospital in The Hague, Netherlands, realized the way asthma and pregnancy care were organized in her home country was not ideal.

Patients with severe asthma saw less escalation of care after uncontrolled disease, with non-white patients showing significantly less care, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

SAN DIEGO — Greenhouse gas emissions associated with severe asthma care are a substantial portion of the health care carbon footprint in the U.K., according to a poster presented at the American Thoracic Society International Conference.